[The role of FDG-PET-CT in the evaluation of primary systemic therapy in breast cancer: links between metabolic and pathological remission].

@article{Tks2012TheRO,
  title={[The role of FDG-PET-CT in the evaluation of primary systemic therapy in breast cancer: links between metabolic and pathological remission].},
  author={T{\'i}mea Tők{\'e}s and Kriszti{\'a}n Somlai and B Szekely and Janina Kulka and Gy{\"o}ngyv{\'e}r Szentm{\'a}rtoni and L{\'a}szl{\'o} Torgy{\'i}k and Hajna Galg{\'o}czy and Zsolt Lengyel and Tam{\'a}s Gy{\"o}rke and Magdolna Dank},
  journal={Orvosi hetilap},
  year={2012},
  volume={153 49},
  pages={
          1958-64
        }
}
  • Tímea Tőkés, Krisztián Somlai, +7 authors Magdolna Dank
  • Published in Orvosi hetilap 2012
  • Medicine
  • INTRODUCTION FDG-PET-CT is highly sensitive in detection of viable tumour tissue, giving an importance for that in oncological diagnostics. AIM The authors analysed retrospectively the relationship between metabolic response and changes in Ki-67, a proliferation marker. METHODS Staging FDG-PET-CT scans (before and after therapy) SUVs (Standardized Uptake Value), and morphological changes in the primary tumour and axillary lymph node region were evaluated in 30 patients with breast cancer… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.